US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

10.62

-0.8500-7.41%

Post-market: 10.830.2100+1.98%19:30 EDT

Volume:2.39M

Turnover:25.74M

Market Cap:2.32B

PE:-7.51

High:11.43

Open:11.43

Low:10.54

Close:11.47

52wk High:16.44

52wk Low:6.23

Shares:218.91M

Float Shares:185.00M

Volume Ratio:1.08

T/O Rate:1.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4140

EPS(LYR):-1.4203

ROE:-72.99%

ROA:-34.95%

PB:4.47

PE(LYR):-7.48

Loading ...

Overview Company News Filings

Assessing Ocular Therapeutix (OCUL) Valuation As AXPAXLI Prospects Drive A Wide Gap To Fair Value Estimates

Simply Wall St.

Ocular Therapeutix to host investor day webcast

Ocular Therapeutix grants inducement equity awards to new hires under 2019 plan

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study

Benzinga_recent_news

Ocular Therapeutix Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

BUZZ-Ocular Therapeutix rises as new eye drug shows longer disease control

Ocular Therapeutix posts positive week-52 data from SOL-1 Phase 3 AXPAXLI trial

Ocular Therapeutix™ Announces Additional Positive Week 52 Data From Landmark Sol-1 Phase 3 Trial of Axpaxli™ in Wet Amd

THOMSON REUTERS

Ocular Therapeutix Inc - Axpaxli Meets Statistical Significance in Multiple Secondary Endpoints in Sol-1 Trial

THOMSON REUTERS

How Axpaxli Phase 3 Anticipation from Key Ophthalmology Meetings Will Impact Ocular Therapeutix (OCUL) Investors

Simply Wall St.

Piper Sandler Remains a Buy on Ocular Therapeutix (OCUL)

Will Ocular Therapeutix’s (OCUL) AXPAXLI Data Spotlight Redefine Its Retinal Competitive Positioning?

Simply Wall St.

Ocular Therapeutix to present additional SOL-1 Phase 3 AXPAXLI wet AMD data in April

Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Ocular Therapeutix (OCUL)

Why Ocular Therapeutix (OCUL) Is Down 7.7% After Single‑Trial FDA Plan For AXPAXLI Superiority Claim

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL) and Rhythm Pharmaceuticals (RYTM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/OCUL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OCUL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCUL\",,,,,undefined,":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":10.62,"timestamp":1789070400000,"preClose":11.47,"halted":0,"volume":2391778,"hourTrading":{"tag":"盘后","latestPrice":10.83,"preClose":10.62,"latestTime":"19:30 EDT","volume":59114,"amount":627974.4043,"timestamp":1789083009786,"change":0.21,"changeRate":0.019774,"amplitude":0.019774},"delay":0,"changeRate":-0.07410636442894519,"floatShares":185000000,"shares":218906099,"eps":-1.414022,"marketStatus":"Closed","change":-0.85,"latestTime":"09-10 16:00:00 EDT","open":11.43,"high":11.43,"low":10.535,"amount":25739104.596332002,"amplitude":0.07803,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.414022,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1406260800000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.05,"preClose":11.47,"latestTime":"09:27 EDT","volume":605,"amount":6801.851045,"timestamp":1789046846526,"change":-0.42,"changeRate":-0.036617,"amplitude":0.036617},"postHourTrading":{"tag":"盘后","latestPrice":10.83,"preClose":10.62,"latestTime":"19:30 EDT","volume":59114,"amount":627974.4043,"timestamp":1789083009786,"change":0.21,"changeRate":0.019774,"amplitude":0.019774},"volumeRatio":1.082598,"impliedVol":0.823,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCUL\",,,,,undefined,":{"symbol":"OCUL","floatShares":185000000,"roa":"-34.95%","roe":"-72.99%","lyrEps":-1.420299,"volumeRatio":1.082598,"shares":218906099,"dividePrice":0,"high":11.43,"amplitude":0.07803,"preClose":11.47,"low":10.535,"week52Low":6.2301,"pbRate":"4.47","psRate":"44.66","week52High":16.44,"institutionHeld":0,"latestPrice":10.62,"eps":-1.414022,"divideRate":0,"volume":2391778,"delay":0,"ttmEps":-1.414022,"open":11.43,"prevYearClose":12.14,"prevWeekClose":10.64,"prevMonthClose":10.49,"prevQuarterClose":9.82,"fiveDayClose":10.9,"twentyDayClose":10.23,"sixtyDayClose":8.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCUL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"OCUL","fiscalQuarterEnding":"2026/06","expectedEps":-0.4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2026-05-05","symbol":"OCUL","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.41},{"date":"2026-02-05","symbol":"OCUL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770282000000,"name":null,"time":"Pre-MKt","dateTimestamp":1770267600000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"OCUL","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-08-05","symbol":"OCUL","fiscalQuarterEnding":"2025/06","expectedEps":-0.35,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCUL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OCUL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1757995200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OCUL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OCUL","date":"2026-09-09","current":-7.510491,"percent":0.410915,"low":-65.357579,"twenty":-10.838703,"median":-7.629146,"eighty":-5.484238,"high":-2.025529,"avg":-9.821871,"sd":9.794062,"marketCap":2497032419},"quantilePoints":[{"date":"2021-09-10","current":-8.088698,"twenty":-7.108368,"median":-4.229028,"eighty":-3.161729,"marketCap":832456416},{"date":"2021-09-17","current":-7.850576,"twenty":-7.126844,"median":-4.229028,"eighty":-3.161729,"marketCap":807949879},{"date":"2021-09-24","current":-7.805928,"twenty":-7.166094,"median":-4.229028,"eighty":-3.161729,"marketCap":803354904},{"date":"2021-10-01","current":-7.716633,"twenty":-7.199885,"median":-4.229028,"eighty":-3.161729,"marketCap":794164952},{"date":"2021-10-08","current":-7.255272,"twenty":-7.221044,"median":-4.229028,"eighty":-3.161729,"marketCap":746683538},{"date":"2021-10-15","current":-8.326819,"twenty":-7.255307,"median":-4.229028,"eighty":-3.161729,"marketCap":856962953},{"date":"2021-10-22","current":-5.141941,"twenty":-7.285114,"median":-4.229028,"eighty":-3.161729,"marketCap":529188025},{"date":"2021-10-29","current":-4.941026,"twenty":-7.285114,"median":-4.229028,"eighty":-3.161729,"marketCap":508510635},{"date":"2021-11-05","current":-5.186589,"twenty":-7.285114,"median":-4.240574,"eighty":-3.161729,"marketCap":533783001},{"date":"2021-11-12","current":-6.04623,"twenty":-7.285114,"median":-4.242896,"eighty":-3.161729,"marketCap":533972766},{"date":"2021-11-19","current":-5.803339,"twenty":-7.284102,"median":-4.242896,"eighty":-3.161729,"marketCap":512521923},{"date":"2021-11-26","current":-5.67322,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":501030400},{"date":"2021-12-03","current":-5.343583,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":471918542},{"date":"2021-12-10","current":-5.681894,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":501796502},{"date":"2021-12-17","current":-6.063579,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":535504969},{"date":"2021-12-23","current":-6.263096,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":553125304},{"date":"2021-12-31","current":-6.04623,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":533972766},{"date":"2022-01-07","current":-5.586473,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":493369385},{"date":"2022-01-14","current":-5.378282,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":474982948},{"date":"2022-01-21","current":-4.771056,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":421355841},{"date":"2022-01-28","current":-4.640937,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":409864318},{"date":"2022-02-04","current":-4.745032,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":419057536},{"date":"2022-02-11","current":-4.736358,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":418291435},{"date":"2022-02-18","current":-4.250577,"twenty":-7.249318,"median":-4.246736,"eighty":-3.162843,"marketCap":375389749},{"date":"2022-02-25","current":-4.788406,"twenty":-7.249318,"median":-4.241898,"eighty":-3.162843,"marketCap":422888044},{"date":"2022-03-04","current":-57.744241,"twenty":-7.285075,"median":-4.241898,"eighty":-3.162843,"marketCap":378398008},{"date":"2022-03-11","current":-62.195115,"twenty":-7.340609,"median":-4.241898,"eighty":-3.162843,"marketCap":407564589},{"date":"2022-03-18","current":-61.84373,"twenty":-7.362814,"median":-4.241898,"eighty":-3.162843,"marketCap":405261964},{"date":"2022-03-25","current":-59.735421,"twenty":-7.406344,"median":-4.241898,"eighty":-3.162843,"marketCap":391446216},{"date":"2022-04-01","current":-56.807214,"twenty":-7.449214,"median":-4.241898,"eighty":-3.162843,"marketCap":372257676},{"date":"2022-04-08","current":-54.816034,"twenty":-7.466341,"median":-4.241898,"eighty":-3.162843,"marketCap":359209468},{"date":"2022-04-14","current":-51.302185,"twenty":-7.515877,"median":-4.241898,"eighty":-3.162843,"marketCap":336183220},{"date":"2022-04-22","current":-42.868949,"twenty":-7.572917,"median":-4.241898,"eighty":-3.162843,"marketCap":280920225},{"date":"2022-04-29","current":-41.814795,"twenty":-7.665046,"median":-4.241898,"eighty":-3.162843,"marketCap":274012351},{"date":"2022-05-06","current":-40.6464,"twenty":-7.700971,"median":-4.241898,"eighty":-3.162843,"marketCap":266355860},{"date":"2022-05-13","current":-11.332892,"twenty":-7.733621,"median":-4.241898,"eighty":-3.162843,"marketCap":251771533},{"date":"2022-05-20","current":-11.574753,"twenty":-7.788471,"median":-4.241898,"eighty":-3.162843,"marketCap":257144706},{"date":"2022-05-27","current":-11.021929,"twenty":-7.811217,"median":-4.241898,"eighty":-3.162843,"marketCap":244863168},{"date":"2022-06-03","current":-10.849171,"twenty":-7.856528,"median":-4.241898,"eighty":-3.162843,"marketCap":241025187},{"date":"2022-06-10","current":-12.749504,"twenty":-7.880577,"median":-4.241898,"eighty":-3.162843,"marketCap":283242975},{"date":"2022-06-17","current":-12.922261,"twenty":-7.936523,"median":-4.241898,"eighty":-3.162843,"marketCap":287080956},{"date":"2022-06-24","current":-13.786049,"twenty":-7.987496,"median":-4.240899,"eighty":-3.161729,"marketCap":306270859},{"date":"2022-07-01","current":-14.131564,"twenty":-8.024062,"median":-4.240899,"eighty":-3.161729,"marketCap":313946821},{"date":"2022-07-08","current":-15.513624,"twenty":-8.058933,"median":-4.240899,"eighty":-3.161729,"marketCap":344650666},{"date":"2022-07-15","current":-14.9608,"twenty":-8.088698,"median":-4.240899,"eighty":-3.161729,"marketCap":332369128},{"date":"2022-07-22","current":-15.099006,"twenty":-8.134478,"median":-4.240899,"eighty":-3.161729,"marketCap":335439513},{"date":"2022-07-29","current":-15.479072,"twenty":-8.181941,"median":-4.240899,"eighty":-3.161729,"marketCap":343883070},{"date":"2022-08-05","current":-17.137544,"twenty":-8.215678,"median":-4.250577,"eighty":-3.161729,"marketCap":380727685},{"date":"2022-08-12","current":-12.977402,"twenty":-8.304373,"median":-4.275211,"eighty":-3.161729,"marketCap":421778551},{"date":"2022-08-19","current":-12.385367,"twenty":-8.35569,"median":-4.302833,"eighty":-3.161729,"marketCap":402536829},{"date":"2022-08-26","current":-12.030147,"twenty":-8.397759,"median":-4.330109,"eighty":-3.161729,"marketCap":390991796},{"date":"2022-09-02","current":-12.5985,"twenty":-8.440803,"median":-4.371283,"eighty":-3.161729,"marketCap":409463849},{"date":"2022-09-09","current":-14.161472,"twenty":-8.508816,"median":-4.37685,"eighty":-3.161729,"marketCap":460261996},{"date":"2022-09-16","current":-13.900977,"twenty":-8.602312,"median":-4.412457,"eighty":-3.161729,"marketCap":451795638},{"date":"2022-09-23","current":-12.527456,"twenty":-8.726496,"median":-4.426181,"eighty":-3.161729,"marketCap":407154842},{"date":"2022-09-30","current":-9.827777,"twenty":-8.861778,"median":-4.45363,"eighty":-3.161729,"marketCap":319412589},{"date":"2022-10-07","current":-10.254042,"twenty":-9.114761,"median":-4.525226,"eighty":-3.161729,"marketCap":333266629},{"date":"2022-10-14","current":-9.756733,"twenty":-9.354149,"median":-4.545515,"eighty":-3.161729,"marketCap":317103582},{"date":"2022-10-21","current":-8.714752,"twenty":-9.396835,"median":-4.597563,"eighty":-3.161729,"marketCap":283238151},{"date":"2022-10-28","current":-8.714752,"twenty":-9.396835,"median":-4.657209,"eighty":-3.161729,"marketCap":283238151},{"date":"2022-11-04","current":-8.288487,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":269384111},{"date":"2022-11-11","current":-4.243318,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":251823958},{"date":"2022-11-18","current":-3.866999,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":229490947},{"date":"2022-11-25","current":-3.918905,"twenty":-9.396835,"median":-4.714285,"eighty":-3.166402,"marketCap":232571362},{"date":"2022-12-02","current":-4.061647,"twenty":-9.396835,"median":-4.714285,"eighty":-3.189035,"marketCap":241042505},{"date":"2022-12-09","current":-3.386869,"twenty":-9.396835,"median":-4.714285,"eighty":-3.193879,"marketCap":200997104},{"date":"2022-12-16","current":-3.542587,"twenty":-9.396835,"median":-4.714285,"eighty":-3.197244,"marketCap":210238351},{"date":"2022-12-23","current":-3.464728,"twenty":-9.396835,"median":-4.714285,"eighty":-3.199668,"marketCap":205617727},{"date":"2022-12-30","current":-3.646399,"twenty":-9.396835,"median":-4.714285,"eighty":-3.225948,"marketCap":216399181},{"date":"2023-01-06","current":-4.788331,"twenty":-9.396835,"median":-4.72126,"eighty":-3.244829,"marketCap":284168320},{"date":"2023-01-13","current":-5.190603,"twenty":-9.396835,"median":-4.727683,"eighty":-3.261462,"marketCap":308041540},{"date":"2023-01-20","current":-5.320368,"twenty":-9.396835,"median":-4.745032,"eighty":-3.290783,"marketCap":315742578},{"date":"2023-01-27","current":-5.034885,"twenty":-9.396835,"median":-4.773486,"eighty":-3.304947,"marketCap":298800293},{"date":"2023-02-03","current":-5.605851,"twenty":-9.396835,"median":-4.786157,"eighty":-3.313433,"marketCap":332684863},{"date":"2023-02-10","current":-5.021909,"twenty":-9.396835,"median":-4.801308,"eighty":-3.335884,"marketCap":298030189},{"date":"2023-02-17","current":-8.136271,"twenty":-9.396835,"median":-4.837745,"eighty":-3.359534,"marketCap":482855113},{"date":"2023-02-24","current":-7.682093,"twenty":-9.396835,"median":-4.869154,"eighty":-3.374399,"marketCap":455901479},{"date":"2023-03-03","current":-7.669116,"twenty":-9.396835,"median":-4.883827,"eighty":-3.384317,"marketCap":455131375},{"date":"2023-03-10","current":-5.313628,"twenty":-9.396835,"median":-4.901176,"eighty":-3.384317,"marketCap":377469482},{"date":"2023-03-17","current":-5.411826,"twenty":-9.396835,"median":-4.920363,"eighty":-3.384317,"marketCap":384445304},{"date":"2023-03-24","current":-5.368182,"twenty":-9.396835,"median":-4.941026,"eighty":-3.384317,"marketCap":381344939},{"date":"2023-03-31","current":-5.750065,"twenty":-9.394491,"median":-4.967452,"eighty":-3.384544,"marketCap":408473136},{"date":"2023-04-06","current":-5.368182,"twenty":-9.394491,"median":-5.006377,"eighty":-3.384544,"marketCap":381344939},{"date":"2023-04-14","current":-5.880997,"twenty":-9.396835,"median":-5.030322,"eighty":-3.384317,"marketCap":417774232},{"date":"2023-04-21","current":-6.241058,"twenty":-9.396835,"median":-5.03664,"eighty":-3.384317,"marketCap":443352246},{"date":"2023-04-28","current":-6.557475,"twenty":-9.396835,"median":-5.073815,"eighty":-3.384317,"marketCap":465829895},{"date":"2023-05-05","current":-6.646015,"twenty":-9.396835,"median":-5.092018,"eighty":-3.384317,"marketCap":472119588},{"date":"2023-05-12","current":-5.455484,"twenty":-9.396835,"median":-5.131977,"eighty":-3.384317,"marketCap":484523387},{"date":"2023-05-19","current":-5.560296,"twenty":-9.396835,"median":-5.152917,"eighty":-3.384317,"marketCap":493832122},{"date":"2023-05-26","current":-5.44682,"twenty":-9.396835,"median":-5.189636,"eighty":-3.384317,"marketCap":483753915},{"date":"2023-06-01","current":-5.586483,"twenty":-9.396835,"median":-5.194225,"eighty":-3.384317,"marketCap":496157862},{"date":"2023-06-09","current":-6.642677,"twenty":-9.39918,"median":-5.235535,"eighty":-3.384091,"marketCap":589962708},{"date":"2023-06-16","current":-4.338253,"twenty":-9.39918,"median":-5.255258,"eighty":-3.384091,"marketCap":385297590},{"date":"2023-06-23","current":-4.015284,"twenty":-9.401524,"median":-5.256955,"eighty":-3.383864,"marketCap":356613463},{"date":"2023-06-30","current":-4.425542,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":393050056},{"date":"2023-07-07","current":-4.233506,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":375994630},{"date":"2023-07-14","current":-4.024013,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":357388710},{"date":"2023-07-21","current":-3.936724,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":349636243},{"date":"2023-07-28","current":-3.762147,"twenty":-9.403869,"median":-5.262699,"eighty":-3.384771,"marketCap":334131310},{"date":"2023-08-04","current":-3.849436,"twenty":-9.403869,"median":-5.262699,"eighty":-3.392505,"marketCap":341883777},{"date":"2023-08-11","current":-3.412339,"twenty":-9.403869,"median":-5.262699,"eighty":-3.399374,"marketCap":309601476},{"date":"2023-08-18","current":-3.771072,"twenty":-9.403869,"median":-5.262699,"eighty":-3.399374,"marketCap":342149324},{"date":"2023-08-25","current":-3.289844,"twenty":-9.403869,"median":-5.262699,"eighty":-3.391505,"marketCap":298487577},{"date":"2023-09-01","current":-3.307344,"twenty":-9.403869,"median":-5.262699,"eighty":-3.380757,"marketCap":300075277},{"date":"2023-09-08","current":-3.351091,"twenty":-9.403869,"median":-5.262699,"eighty":-3.375768,"marketCap":304044527},{"date":"2023-09-15","current":-3.158601,"twenty":-9.403869,"median":-5.262699,"eighty":-3.368591,"marketCap":286579828},{"date":"2023-09-22","current":-2.852365,"twenty":-9.403869,"median":-5.262699,"eighty":-3.351091,"marketCap":258795080},{"date":"2023-09-29","current":-2.791118,"twenty":-9.403869,"median":-5.262699,"eighty":-3.321084,"marketCap":253238130},{"date":"2023-10-06","current":-2.607377,"twenty":-9.403869,"median":-5.262699,"eighty":-3.307344,"marketCap":236567282},{"date":"2023-10-13","current":-2.213645,"twenty":-9.403869,"median":-5.262699,"eighty":-3.299204,"marketCap":200844034},{"date":"2023-10-20","current":-2.025529,"twenty":-9.403869,"median":-5.262699,"eighty":-3.278629,"marketCap":183776261},{"date":"2023-10-27","current":-2.152398,"twenty":-9.439644,"median":-5.283326,"eighty":-3.260219,"marketCap":195287085},{"date":"2023-11-03","current":-2.861115,"twenty":-9.439644,"median":-5.283326,"eighty":-3.241754,"marketCap":259588930},{"date":"2023-11-10","current":-2.528539,"twenty":-9.439644,"median":-5.283326,"eighty":-3.2138,"marketCap":169558766},{"date":"2023-11-17","current":-2.463401,"twenty":-9.439644,"median":-5.283326,"eighty":-3.199668,"marketCap":165190742},{"date":"2023-11-24","current":-2.652893,"twenty":-9.439644,"median":-5.283326,"eighty":-3.195033,"marketCap":177897722},{"date":"2023-12-01","current":-2.937132,"twenty":-9.439644,"median":-5.283326,"eighty":-3.187346,"marketCap":196958192},{"date":"2023-12-08","current":-4.405698,"twenty":-9.427719,"median":-5.275885,"eighty":-3.181747,"marketCap":295437288},{"date":"2023-12-15","current":-6.229363,"twenty":-9.427719,"median":-5.291431,"eighty":-3.181747,"marketCap":417728592},{"date":"2023-12-22","current":-6.788197,"twenty":-9.427719,"median":-5.320368,"eighty":-3.187563,"marketCap":455202925},{"date":"2023-12-29","current":-7.429213,"twenty":-9.439644,"median":-5.333345,"eighty":-3.193428,"marketCap":498188189},{"date":"2024-01-05","current":-7.248414,"twenty":-9.451569,"median":-5.343583,"eighty":-3.198707,"marketCap":486064140},{"date":"2024-01-12","current":-7.248414,"twenty":-9.451569,"median":-5.368182,"eighty":-3.206784,"marketCap":486064140},{"date":"2024-01-19","current":-6.459471,"twenty":-9.463494,"median":-5.411826,"eighty":-3.238548,"marketCap":433159200},{"date":"2024-01-26","current":-7.051178,"twenty":-9.451569,"median":-5.44682,"eighty":-3.25699,"marketCap":472837905},{"date":"2024-02-02","current":-8.629064,"twenty":-9.451569,"median":-5.474221,"eighty":-3.281144,"marketCap":578647786},{"date":"2024-02-09","current":-8.267465,"twenty":-9.451569,"median":-5.496861,"eighty":-3.299371,"marketCap":554399688},{"date":"2024-02-16","current":-11.275311,"twenty":-9.64194,"median":-5.528613,"eighty":-3.313041,"marketCap":756099774},{"date":"2024-02-23","current":-15.943223,"twenty":-9.755565,"median":-5.551567,"eighty":-3.33764,"marketCap":1069120672},{"date":"2024-03-01","current":-16.534931,"twenty":-9.849606,"median":-5.569025,"eighty":-3.345816,"marketCap":1108799377},{"date":"2024-03-08","current":-17.044456,"twenty":-9.971199,"median":-5.597312,"eighty":-3.351091,"marketCap":1142967151},{"date":"2024-03-15","current":-17.046796,"twenty":-10.152659,"median":-5.619134,"eighty":-3.365798,"marketCap":1376290085},{"date":"2024-03-22","current":-18.685202,"twenty":-10.301095,"median":-5.654745,"eighty":-3.378916,"marketCap":1508568505},{"date":"2024-03-28","current":-17.138841,"twenty":-10.400002,"median":-5.664545,"eighty":-3.391505,"marketCap":1383721457},{"date":"2024-04-05","current":-15.592479,"twenty":-10.637061,"median":-5.682197,"eighty":-3.403589,"marketCap":1258874408},{"date":"2024-04-12","current":-15.242707,"twenty":-10.969382,"median":-5.713045,"eighty":-3.414089,"marketCap":1230635194},{"date":"2024-04-19","current":-10.787713,"twenty":-11.273007,"median":-5.726028,"eighty":-3.425798,"marketCap":870956792},{"date":"2024-04-26","current":-8.047924,"twenty":-11.270702,"median":-5.742617,"eighty":-3.440231,"marketCap":649757161},{"date":"2024-05-03","current":-11.249554,"twenty":-11.270702,"median":-5.760976,"eighty":-3.454073,"marketCap":908243991},{"date":"2024-05-10","current":-7.847512,"twenty":-11.30986,"median":-5.794665,"eighty":-3.48638,"marketCap":904551263},{"date":"2024-05-17","current":-8.425325,"twenty":-11.30986,"median":-5.820689,"eighty":-3.50045,"marketCap":971153497},{"date":"2024-05-24","current":-7.793761,"twenty":-11.30986,"median":-5.872737,"eighty":-3.519115,"marketCap":898355707},{"date":"2024-05-31","current":-7.659386,"twenty":-11.30986,"median":-5.91611,"eighty":-3.535148,"marketCap":882866815},{"date":"2024-06-07","current":-6.638135,"twenty":-11.30986,"median":-5.968158,"eighty":-3.549802,"marketCap":765151240},{"date":"2024-06-14","current":-7.726574,"twenty":-11.30986,"median":-6.037555,"eighty":-3.564515,"marketCap":890611261},{"date":"2024-06-21","current":-8.39845,"twenty":-11.321376,"median":-6.04623,"eighty":-3.594493,"marketCap":968055718},{"date":"2024-06-28","current":-9.191263,"twenty":-11.321376,"median":-6.065075,"eighty":-3.619852,"marketCap":1059440178},{"date":"2024-07-05","current":-8.962826,"twenty":-11.321376,"median":-6.097628,"eighty":-3.623326,"marketCap":1033109063},{"date":"2024-07-12","current":-10.924704,"twenty":-11.321376,"median":-6.126684,"eighty":-3.623326,"marketCap":1259246878},{"date":"2024-07-19","current":-10.548453,"twenty":-11.331879,"median":-6.15093,"eighty":-3.628327,"marketCap":1215877982},{"date":"2024-07-26","current":-11.327829,"twenty":-11.331879,"median":-6.246513,"eighty":-3.659921,"marketCap":1305713553},{"date":"2024-08-02","current":-10.45439,"twenty":-11.332892,"median":-6.294458,"eighty":-3.694721,"marketCap":1205035758},{"date":"2024-08-09","current":-9.398507,"twenty":-11.332892,"median":-6.363017,"eighty":-3.740471,"marketCap":1300386852},{"date":"2024-08-16","current":-9.139316,"twenty":-11.332892,"median":-6.44211,"eighty":-3.763187,"marketCap":1264524865},{"date":"2024-08-23","current":-10.266235,"twenty":-11.332892,"median":-6.480732,"eighty":-3.788231,"marketCap":1420446550},{"date":"2024-08-30","current":-9.939428,"twenty":-11.332892,"median":-6.557475,"eighty":-3.816724,"marketCap":1375229261},{"date":"2024-09-06","current":-9.454853,"twenty":-11.332892,"median":-6.583321,"eighty":-3.837162,"marketCap":1308182937},{"date":"2024-09-13","current":-10.142274,"twenty":-11.332892,"median":-6.62319,"eighty":-3.850659,"marketCap":1403295165},{"date":"2024-09-20","current":-10.119736,"twenty":-11.332892,"median":-6.65744,"eighty":-3.882597,"marketCap":1400176731},{"date":"2024-09-27","current":-9.78166,"twenty":-11.332892,"median":-6.734976,"eighty":-3.917476,"marketCap":1353400225},{"date":"2024-10-04","current":-11.088886,"twenty":-11.332892,"median":-6.764783,"eighty":-3.936724,"marketCap":1534269380},{"date":"2024-10-11","current":-11.021271,"twenty":-11.332892,"median":-6.804633,"eighty":-3.964491,"marketCap":1524914079},{"date":"2024-10-18","current":-12.767996,"twenty":-11.524097,"median":-6.881776,"eighty":-4.001318,"marketCap":1766592691},{"date":"2024-10-25","current":-12.553881,"twenty":-11.779563,"median":-7.054721,"eighty":-4.046171,"marketCap":1736967570},{"date":"2024-11-01","current":-11.708692,"twenty":-11.959519,"median":-7.112227,"eighty":-4.085278,"marketCap":1620026307},{"date":"2024-11-08","current":-12.508805,"twenty":-12.028902,"median":-7.184646,"eighty":-4.113553,"marketCap":1730730703},{"date":"2024-11-15","current":-8.260457,"twenty":-12.030147,"median":-7.21972,"eighty":-4.156039,"marketCap":1440111631},{"date":"2024-11-22","current":-7.962865,"twenty":-12.030147,"median":-7.248414,"eighty":-4.176445,"marketCap":1388229880},{"date":"2024-11-29","current":-8.918769,"twenty":-12.030147,"median":-7.304401,"eighty":-4.191602,"marketCap":1554880353},{"date":"2024-12-06","current":-8.675284,"twenty":-12.030147,"median":-7.380818,"eighty":-4.240028,"marketCap":1512431647},{"date":"2024-12-13","current":-7.836613,"twenty":-12.030147,"median":-7.426828,"eighty":-4.272191,"marketCap":1366219440},{"date":"2024-12-20","current":-7.665272,"twenty":-12.030147,"median":-7.456187,"eighty":-4.324295,"marketCap":1336348129},{"date":"2024-12-27","current":-7.611164,"twenty":-12.030147,"median":-7.48036,"eighty":-4.36444,"marketCap":1326915083},{"date":"2025-01-03","current":-7.899739,"twenty":-12.030147,"median":-7.5217,"eighty":-4.400624,"marketCap":1377224660},{"date":"2025-01-10","current":-7.403751,"twenty":-12.030147,"median":-7.560704,"eighty":-4.545515,"marketCap":1290755075},{"date":"2025-01-17","current":-7.223391,"twenty":-12.030147,"median":-7.560704,"eighty":-4.60666,"marketCap":1259311590},{"date":"2025-01-24","current":-7.187319,"twenty":-12.030147,"median":-7.560704,"eighty":-4.657209,"marketCap":1253022893},{"date":"2025-01-31","current":-6.943834,"twenty":-12.030147,"median":-7.560704,"eighty":-4.730826,"marketCap":1210574187},{"date":"2025-02-07","current":-6.826601,"twenty":-12.030147,"median":-7.560704,"eighty":-4.771056,"marketCap":1190135922},{"date":"2025-02-14","current":-6.56508,"twenty":-12.030147,"median":-7.560704,"eighty":-4.786157,"marketCap":1144542868},{"date":"2025-02-21","current":-6.312577,"twenty":-12.030147,"median":-7.560704,"eighty":-4.801308,"marketCap":1100521989},{"date":"2025-02-28","current":-6.438828,"twenty":-12.030147,"median":-7.560704,"eighty":-4.840454,"marketCap":1122532428},{"date":"2025-03-07","current":-6.196334,"twenty":-12.049092,"median":-7.565589,"eighty":-4.868603,"marketCap":1199027727},{"date":"2025-03-14","current":-6.344257,"twenty":-12.049092,"median":-7.565589,"eighty":-4.881584,"marketCap":1227651731},{"date":"2025-03-21","current":-6.17168,"twenty":-12.049092,"median":-7.565589,"eighty":-4.903224,"marketCap":1194257059},{"date":"2025-03-28","current":-6.229205,"twenty":-12.049092,"median":-7.565589,"eighty":-4.93505,"marketCap":1205388617},{"date":"2025-04-04","current":-5.222507,"twenty":-12.049092,"median":-7.565589,"eighty":-4.967875,"marketCap":1010586366},{"date":"2025-04-11","current":-5.842962,"twenty":-12.030147,"median":-7.560704,"eighty":-5.007482,"marketCap":1130648161},{"date":"2025-04-17","current":-6.007321,"twenty":-12.030147,"median":-7.560704,"eighty":-5.0244,"marketCap":1162452610},{"date":"2025-04-25","current":-6.346583,"twenty":-12.049092,"median":-7.565589,"eighty":-5.036289,"marketCap":1228101960},{"date":"2025-05-02","current":-7.243831,"twenty":-12.049092,"median":-7.565589,"eighty":-5.07122,"marketCap":1401724676},{"date":"2025-05-09","current":-5.835973,"twenty":-12.049092,"median":-7.565589,"eighty":-5.091019,"marketCap":1124656136},{"date":"2025-05-16","current":-5.968233,"twenty":-12.049092,"median":-7.565589,"eighty":-5.131269,"marketCap":1150144093},{"date":"2025-05-23","current":-5.9641,"twenty":-12.049092,"median":-7.565589,"eighty":-5.152879,"marketCap":1149347595},{"date":"2025-05-30","current":-6.728728,"twenty":-12.049092,"median":-7.565589,"eighty":-5.177397,"marketCap":1296699851},{"date":"2025-06-06","current":-6.993248,"twenty":-12.049092,"median":-7.565589,"eighty":-5.194225,"marketCap":1347675766},{"date":"2025-06-13","current":-7.398294,"twenty":-12.049092,"median":-7.565589,"eighty":-5.221891,"marketCap":1425732637},{"date":"2025-06-20","current":-6.885786,"twenty":-12.068037,"median":-7.570474,"eighty":-5.221891,"marketCap":1326966800},{"date":"2025-06-27","current":-7.819873,"twenty":-12.068037,"median":-7.582689,"eighty":-5.221891,"marketCap":1506975502},{"date":"2025-07-03","current":-7.952133,"twenty":-12.068037,"median":-7.611164,"eighty":-5.221891,"marketCap":1532463460},{"date":"2025-07-11","current":-9.159005,"twenty":-12.068037,"median":-7.6464,"eighty":-5.244103,"marketCap":1765041074},{"date":"2025-07-18","current":-9.406993,"twenty":-12.068037,"median":-7.669116,"eighty":-5.255597,"marketCap":1812830995},{"date":"2025-07-25","current":-9.85337,"twenty":-12.068037,"median":-7.686867,"eighty":-5.255597,"marketCap":1898852853},{"date":"2025-08-01","current":-9.572318,"twenty":-12.068037,"median":-7.709191,"eighty":-5.255597,"marketCap":1844690942},{"date":"2025-08-08","current":-9.873868,"twenty":-12.068037,"median":-7.726574,"eighty":-5.26094,"marketCap":2140141218},{"date":"2025-08-15","current":-10.154832,"twenty":-12.068037,"median":-7.751329,"eighty":-5.309264,"marketCap":2201039545},{"date":"2025-08-22","current":-9.7374,"twenty":-12.068037,"median":-7.788453,"eighty":-5.322711,"marketCap":2110562030},{"date":"2025-08-29","current":-10.050474,"twenty":-12.068037,"median":-7.805928,"eighty":-5.338338,"marketCap":2178420166},{"date":"2025-09-05","current":-10.19497,"twenty":-12.086982,"median":-7.820543,"eighty":-5.359952,"marketCap":2209739306},{"date":"2025-09-12","current":-10.251163,"twenty":-12.068037,"median":-7.837811,"eighty":-5.371996,"marketCap":2221918972},{"date":"2025-09-19","current":-10.202997,"twenty":-12.068037,"median":-7.858017,"eighty":-5.398408,"marketCap":2211479258},{"date":"2025-09-26","current":-9.825703,"twenty":-12.068037,"median":-7.880341,"eighty":-5.452018,"marketCap":2129701505},{"date":"2025-10-03","current":-8.878454,"twenty":-12.068037,"median":-7.902693,"eighty":-5.482121,"marketCap":1924387144},{"date":"2025-10-10","current":-11.673172,"twenty":-12.068037,"median":-7.918018,"eighty":-5.487961,"marketCap":2530136613},{"date":"2025-10-17","current":-11.927361,"twenty":-12.068037,"median":-7.955158,"eighty":-5.487961,"marketCap":2585231715},{"date":"2025-10-24","current":-11.184345,"twenty":-12.068037,"median":-7.968449,"eighty":-5.487961,"marketCap":2424184494},{"date":"2025-10-31","current":-11.555853,"twenty":-12.068037,"median":-8.006843,"eighty":-5.487961,"marketCap":2504708104},{"date":"2025-11-07","current":-9.070643,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2264694627},{"date":"2025-11-14","current":-9.548494,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2384001211},{"date":"2025-11-21","current":-10.000746,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2496916371},{"date":"2025-11-28","current":-10.367668,"twenty":-12.026412,"median":-8.007954,"eighty":-5.487961,"marketCap":2588526784},{"date":"2025-12-05","current":-10.606594,"twenty":-11.934555,"median":-8.007954,"eighty":-5.487961,"marketCap":2648180076},{"date":"2025-12-12","current":-12.517999,"twenty":-11.917867,"median":-8.007954,"eighty":-5.487961,"marketCap":3125406414},{"date":"2025-12-19","current":-11.075912,"twenty":-11.883,"median":-8.007954,"eighty":-5.487961,"marketCap":2765356186},{"date":"2025-12-26","current":-10.845519,"twenty":-11.763536,"median":-8.007954,"eighty":-5.487961,"marketCap":2707833369},{"date":"2026-01-02","current":-10.359135,"twenty":-11.670239,"median":-8.007954,"eighty":-5.487961,"marketCap":2586396310},{"date":"2026-01-09","current":-9.710622,"twenty":-11.575014,"median":-8.007954,"eighty":-5.487961,"marketCap":2424480231},{"date":"2026-01-16","current":-9.625292,"twenty":-11.510881,"median":-8.007954,"eighty":-5.487961,"marketCap":2403175484},{"date":"2026-01-23","current":-9.488763,"twenty":-11.380657,"median":-8.007954,"eighty":-5.487961,"marketCap":2369087888},{"date":"2026-01-30","current":-8.490395,"twenty":-11.306264,"median":-8.007954,"eighty":-5.487961,"marketCap":2119822346},{"date":"2026-02-06","current":-7.293804,"twenty":-11.255248,"median":-7.988048,"eighty":-5.487961,"marketCap":1939707000},{"date":"2026-02-13","current":-7.416315,"twenty":-11.126266,"median":-7.962196,"eighty":-5.487961,"marketCap":1972287517},{"date":"2026-02-20","current":-5.754602,"twenty":-11.080179,"median":-7.952133,"eighty":-5.487961,"marketCap":1530373206},{"date":"2026-02-27","current":-7.850162,"twenty":-10.982374,"median":-7.917548,"eighty":-5.487961,"marketCap":2087664160},{"date":"2026-03-06","current":-8.455909,"twenty":-10.84698,"median":-7.910913,"eighty":-5.487961,"marketCap":2248756077},{"date":"2026-03-13","current":-7.260786,"twenty":-10.827953,"median":-7.902693,"eighty":-5.487961,"marketCap":1930926079},{"date":"2026-03-20","current":-6.769639,"twenty":-10.827953,"median":-7.880341,"eighty":-5.487961,"marketCap":1800311012},{"date":"2026-03-27","current":-6.605923,"twenty":-10.827953,"median":-7.858017,"eighty":-5.487961,"marketCap":1756772656},{"date":"2026-04-02","current":-6.818754,"twenty":-10.827953,"median":-7.856156,"eighty":-5.487961,"marketCap":1813372519},{"date":"2026-04-10","current":-7.612774,"twenty":-10.827953,"median":-7.836613,"eighty":-5.487961,"marketCap":2024533544},{"date":"2026-04-17","current":-7.2526,"twenty":-10.827953,"median":-7.821213,"eighty":-5.487961,"marketCap":1928749161},{"date":"2026-04-24","current":-7.850162,"twenty":-10.827953,"median":-7.836613,"eighty":-5.487961,"marketCap":2087664160},{"date":"2026-05-01","current":-7.670075,"twenty":-10.827953,"median":-7.821213,"eighty":-5.487961,"marketCap":2039771969},{"date":"2026-05-08","current":-7.296216,"twenty":-10.827953,"median":-7.805928,"eighty":-5.487961,"marketCap":2119536265},{"date":"2026-05-15","current":-7.160543,"twenty":-10.827953,"median":-7.793761,"eighty":-5.487961,"marketCap":2080123401},{"date":"2026-05-22","current":-6.195754,"twenty":-10.827953,"median":-7.77649,"eighty":-5.487961,"marketCap":1799854142},{"date":"2026-05-29","current":-6.896733,"twenty":-10.833328,"median":-7.745143,"eighty":-5.486099,"marketCap":2003487275},{"date":"2026-06-05","current":-6.632924,"twenty":-10.827953,"median":-7.726574,"eighty":-5.487961,"marketCap":1926851150},{"date":"2026-06-12","current":-6.55755,"twenty":-10.827953,"median":-7.710563,"eighty":-5.487961,"marketCap":1904955114},{"date":"2026-06-18","current":-7.266067,"twenty":-10.827953,"median":-7.698916,"eighty":-5.487961,"marketCap":2110777851},{"date":"2026-06-26","current":-7.356516,"twenty":-10.833328,"median":-7.670578,"eighty":-5.486099,"marketCap":2137053094},{"date":"2026-07-02","current":-7.137931,"twenty":-10.833328,"median":-7.661964,"eighty":-5.486099,"marketCap":2073554590},{"date":"2026-07-10","current":-7.944434,"twenty":-10.833328,"median":-7.644755,"eighty":-5.486099,"marketCap":2307842173},{"date":"2026-07-17","current":-6.90804,"twenty":-10.833328,"median":-7.644755,"eighty":-5.486099,"marketCap":2006771681},{"date":"2026-07-24","current":-6.497251,"twenty":-10.833328,"median":-7.644755,"eighty":-5.486099,"marketCap":1887438285},{"date":"2026-07-31","current":-6.384189,"twenty":-10.838703,"median":-7.659322,"eighty":-5.484238,"marketCap":1854594232},{"date":"2026-08-07","current":-6.36743,"twenty":-10.838703,"median":-7.659322,"eighty":-5.484238,"marketCap":1919442686},{"date":"2026-08-14","current":-7.358243,"twenty":-10.838703,"median":-7.621483,"eighty":-5.484238,"marketCap":2218120266},{"date":"2026-08-21","current":-8.079496,"twenty":-10.838703,"median":-7.629146,"eighty":-5.484238,"marketCap":2435539976},{"date":"2026-08-28","current":-7.882791,"twenty":-10.838703,"median":-7.629146,"eighty":-5.484238,"marketCap":2376243691},{"date":"2026-09-04","current":-7.751654,"twenty":-10.838703,"median":-7.629146,"eighty":-5.484238,"marketCap":2336712835},{"date":"2026-09-09","current":-8.283487,"twenty":-10.838703,"median":-7.629146,"eighty":-5.484238,"marketCap":2497032419}],"updateTime":1789074593438},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCUL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629802889","title":"Assessing Ocular Therapeutix (OCUL) Valuation As AXPAXLI Prospects Drive A Wide Gap To Fair Value Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2629802889","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629802889?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:10","pubTimestamp":1776867017,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix (OCUL) has caught investor attention after recent share price swings, with the stock closing at US$9.32. The company focuses on bioresorbable hydrogel therapies for retinal diseases and other eye conditions.\nSee our latest analysis for Ocular Therapeutix.\nRecent trading has been choppy, with a 1 day share price return of 2.1% decline, a 7 day gain of 6.39%, and a 30 day share price return of 13.94%. Even so, the 90 day share price return of 18.39% decline and year to date...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/assessing-ocular-therapeutix-ocul-valuation-as-axpaxli-prosp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/assessing-ocular-therapeutix-ocul-valuation-as-axpaxli-prosp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010787","title":"Ocular Therapeutix to host investor day webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010787?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:02","pubTimestamp":1776855751,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix will host an Investor Day in New York City on June 17, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL72Dy1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","OCUL","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627834448","title":"Ocular Therapeutix grants inducement equity awards to new hires under 2019 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2627834448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627834448?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:06","pubTimestamp":1776164782,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix granted inducement equity awards under its 2019 Inducement Stock Incentive Plan to six newly hired non-executive employees and new SVP CMC Technical Operations Jerome M. Gangitano.Non-executive hires received options for 46,425 shares priced at USD 8.42, plus RSUs for 15,275 shares, effective April 8, 2026.Gangitano received an option for 300,000 shares priced at USD 8.86, plus RSUs for 100,000 shares, effective April 13, 2026.Options carry a 10-year term, with 25% vesting after one year, then monthly vesting over next three years.RSUs vest in equal annual installments over three years.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL8VKbt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4007","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4112","NDAQ","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","OCUL","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4585","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627144819","title":"Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144819","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144819?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:00","pubTimestamp":1776164400,"startTime":"0","endTime":"0","summary":"BEDFORD, Mass., April  14, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina exper","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/14/3273188/0/en/Ocular-Therapeutix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627450630","title":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2627450630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627450630?lang=en_us&edition=fundamental","pubTime":"2026-04-14 01:50","pubTimestamp":1776102619,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0LU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","LUV","ORCL","GFL","CVX","LEG","CRM","COIN","CAG","PINS","DIOD","MARA","UAL","APTV","ALLO","RIOT","IBM","IDYA","IMA","META","ANIP","DOW","HPE","SYRE","XOM","DAL","NEM","AVT","TFX","SBUX","CDE","HL","LYB","SNDK","HUT","OXY","APP","ADBE","BIIB","BBY","GPRO","REPL","EMN","HP","NOW","OCUL","KYMR","DVN","GOOGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627450386","title":"Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627450386","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627450386?lang=en_us&edition=fundamental","pubTime":"2026-04-14 01:31","pubTimestamp":1776101460,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix shares up on positive data for wet AMD treatment. Company focusing on retinal diseases and on track for FDA submission.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/13/Woman-With-Beautiful-Green-Eyes-On-Light.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/13/Woman-With-Beautiful-Green-Eyes-On-Light.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51787616/oculars-axpaxli-cuts-risk-of-worsening-in-late-stage-amd-study","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51787616/oculars-axpaxli-cuts-risk-of-worsening-in-late-stage-amd-study","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0642271901.SGD","LU1852331112.SGD","AMYY","LU0719512351.SGD","IE0004445239.USD","BK4575","AMUU","IE00BMPRXN33.USD","LU1242518931.SGD","LU2360106780.USD","AMDL","BK4585","OCUL","BK4529","LU0889565833.HKD","BK4141","IE0009356076.USD","BK4543","AMDW","LU0823434583.USD","LU1861558580.USD","LU2458330169.SGD","BK4566","IE00BMPRXR70.SGD","BK4605","LU1242518857.USD","LU2054465674.USD","LU2264538146.SGD","LU1923623000.USD","LU2458330243.SGD","LU1316542783.SGD","IE00B5949003.HKD","LU0823421333.USD","LU0390134368.USD","LU1951200564.SGD","LU1989764664.SGD","LU0081259029.USD","LU1064131342.USD","LU0056508442.USD","LU1951198990.SGD","AMDU","LU2355687059.USD","LU0979878070.USD","LU0109392836.USD","BK4614","LU2098885051.SGD","LU1303367103.USD","BK4532","LU1880398471.USD","LU1803068979.SGD","AMDD","AMDY","LU2089985449.USD","LU2931357623.SGD","LU0127658192.USD","LU0082616367.USD","LU0198837287.USD","BK4612","LU0274383776.USD","LU1861559042.SGD","AMDG","LU1880398554.USD","BK4534","LU2250418816.HKD","BK4554","DAMD","LU0823434740.USD","LU2860962120.EUR","BK4588","BK4573","LU1988902786.USD","BK4512","LU0823421416.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445794","title":"Ocular Therapeutix Price Target Maintained With a $21.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445794?lang=en_us&edition=fundamental","pubTime":"2026-04-14 01:08","pubTimestamp":1776100080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OCUL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 13, 2026 13:08 ET (17:08 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627144454","title":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144454?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:43","pubTimestamp":1776095026,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-SonomaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBUX","HTFL","GPRO","HL","AVT","UAL","SYRE","WSM","MARA","META","CAG","IBM","GOOGL","DVN","DIOD","LUV","REPL","SNDK","OCUL","BBY","PINS","EMN","COIN","ANIP","IDYA","OXY","DAL","ALLO","APTV","ADBE","LYB","BIIB","DOW","KYMR","OWL","RIOT","TFX","CRWV","XOM","CDE","SBU","LEG","CVX","HPE","NEM","HUT","RVMD","IMA","AAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627643034","title":"BUZZ-Ocular Therapeutix rises as new eye drug shows longer disease control","url":"https://stock-news.laohu8.com/highlight/detail?id=2627643034","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627643034?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:48","pubTimestamp":1776080900,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix rises as new eye drug shows longer disease control** Shares of Ocular Therapeutix OCUL.O rise 1.6% to $8.93 premarket** Biotech firm says additional late-stage data show its experimental wet AMD drug axpaxli kept eye disease under control for longer than a standard treatment** Adds that patients on axpaxli maintained vision gains for up to a year and showed slower worsening on eye scans versus Bayer’s Aflibercept** Patients took nearly 40 weeks to show moderate disease worsening vs 16 weeks on Aflibercept; safety issues were mostly mild and resolved over time - OCUL** Adds that it plans to seek U.S. approval based on this single late-stage study after recent FDA guidance** Wet AMD is an age-related eye disease that causes vision loss due to abnormal blood vessel growth in the eye** As of last close, stock down ~28% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627043219","title":"Ocular Therapeutix posts positive week-52 data from SOL-1 Phase 3 AXPAXLI trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627043219","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627043219?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:04","pubTimestamp":1776078247,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix released additional Week 52 post-hoc analyses from SOL-1 Phase 3 trial of AXPAXLI in wet age-related macular degeneration, with results already presented at Vit-Buckle Society meeting.New analyses reinforced AXPAXLI durability, showing sustained disease control versus aflibercept.Vision outcomes generally held through one year, supporting potential differentiation in a market dominated by frequent injections.Safety profile remained broadly consistent with prior readouts, with reported vitreous floater events resolving over time without apparent impact on vision.Company kept plan to file US New Drug Application for AXPAXLI based on SOL-1 alone, pending formal FDA discussions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDLcdb6kf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4585","NDAQ","IE00BN0W2T93.GBP","BK4588","SG9999014039.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","OCUL","SG9999014013.SGD","LU0314104364.USD","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2W23.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432624","title":"Ocular Therapeutix™ Announces Additional Positive Week 52 Data From Landmark Sol-1 Phase 3 Trial of Axpaxli™ in Wet Amd","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432624?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA6XWZW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627343293","title":"Ocular Therapeutix Inc - Axpaxli Meets Statistical Significance in Multiple Secondary Endpoints in Sol-1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627343293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627343293?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA6XWZW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627475103","title":"How Axpaxli Phase 3 Anticipation from Key Ophthalmology Meetings Will Impact Ocular Therapeutix (OCUL) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2627475103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627475103?lang=en_us&edition=fundamental","pubTime":"2026-04-13 00:17","pubTimestamp":1776010653,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix recently highlighted its retinal pipeline at major ophthalmology meetings, where senior leaders discussed managing neovascular age-related macular degeneration and the role of tyrosine kinase inhibitors in treating diabetic retinal disease.\nInvestors are closely watching these conference appearances for fresh colour on the phase 3 Axpaxli program, which sits at the centre of the company’s long-term growth plans.\nWe’ll now explore how anticipated Axpaxli phase 3 updates...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/how-axpaxli-phase-3-anticipation-from-key-ophthalmology-meet","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/how-axpaxli-phase-3-anticipation-from-key-ophthalmology-meet","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIYY","ISBC","BK4528","BK4023","BK4587","BK4211","BK4543","BK4551","AGIX","BK4585","BK4588","CHAT","AI","ARTY","OCUL","AIPO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626156194","title":"Piper Sandler Remains a Buy on Ocular Therapeutix (OCUL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626156194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626156194?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:15","pubTimestamp":1775819745,"startTime":"0","endTime":"0","summary":"In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Ocular Therapeutix, with a price target of $31.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ocular-therapeutix-ocul-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ocular-therapeutix-ocul-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625647928","title":"Will Ocular Therapeutix’s (OCUL) AXPAXLI Data Spotlight Redefine Its Retinal Competitive Positioning?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625647928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625647928?lang=en_us&edition=fundamental","pubTime":"2026-04-05 23:19","pubTimestamp":1775402377,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix recently announced that it will present additional data and analyses from its Phase 3 SOL-1 superiority trial of AXPAXLI for wet age-related macular degeneration at multiple scientific conferences in April 2026, highlighting durability, efficacy, and safety outcomes. \nThese upcoming scientific presentations are set to put AXPAXLI’s clinical profile under closer scrutiny from physicians and researchers, potentially sharpening how the therapy is perceived within the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/will-ocular-therapeutixs-ocul-axpaxli-data-spotlight-redefin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/will-ocular-therapeutixs-ocul-axpaxli-data-spotlight-redefin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4543","BK4551","BK4007","SOLX","BK4587","GSOL","AIPO","CHAT","AI","BSOL","SSK","AGIX","SOLZ","OCUL","BK4588","ARTY","SLON","BK4528","AIYY","BK4585","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597264","title":"Ocular Therapeutix to present additional SOL-1 Phase 3 AXPAXLI wet AMD data in April","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597264","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624597264?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:03","pubTimestamp":1775041425,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix scheduled additional data and analyses from SOL-1 Phase 3 superiority trial of AXPAXLI for wet age-related macular degeneration for presentation at scientific meetings in April 2026.New results will be presented in future sessions, including April 11 at Vit-Buckle Society meeting in Las Vegas.Company positioned SOL-1 updates as supporting AXPAXLI as a potential new long-acting treatment option intended to reduce treatment burden in wet AMD.Ocular also slated educational presentations on tyrosine kinase inhibitors, diabetic retinal disease, and neovascular AMD at Congreso Nacional de Oftalmologia in Buenos Aires on April 15.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL3jDMxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014005.SGD","BK4112","IE00BN0W2V16.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","OCUL","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624590886","title":"Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April","url":"https://stock-news.laohu8.com/highlight/detail?id=2624590886","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624590886?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:00","pubTimestamp":1775041200,"startTime":"0","endTime":"0","summary":"BEDFORD, Mass., April  01, 2026  -- Ocular Therapeutix, Inc. , an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in April 2026. Ocular plans to present additional data and analyses from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI , for the treatment of wet age-related macular degeneration . Upcoming Scientific Conferences: 14th Annual Vit-Buckle Society  Meeting: April 9 - 11, 2026Las Vegas, Nevada Symposium Title: Redefining the Management of Neovascular AMDSymposium Date/Time:Saturday, April 11, 2026, 1:15 – 2:00 PM PDTPresenters: Jeffrey S. Heier, MD, Chief Scientific Officer at Ocular Therapeutix, Peter K. Kaiser, MD, Chief Development Officer at Ocular Therapeutix, and Andrew A. Moshfeghi, MD, MBA, FASRS, USC Roski Eye Institute A copy of the VBS symposium presentation will be made available on Ocular’s website following the presentation on Saturday, April 11, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266467/0/en/Ocular-Therapeutix-to-Present-Additional-SOL-1-Data-and-Analyses-at-Upcoming-Scientific-Conferences-in-April.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAMD","BK4162","LU0642271901.SGD","LU1316542783.SGD","LU2089985449.USD","AMDW","LU0082616367.USD","AMYY","AMDD","LU0823421416.USD","BK4512","LU0823421333.USD","BK4588","LU1803068979.SGD","LU2458330243.SGD","LU1861558580.USD","LU1923623000.USD","BK4573","AMD","AMDU","OCUL","BK4612","LU0109392836.USD","BK4575","BSOL","LU2355687059.USD","BK4141","IE00BMPRXR70.SGD","LU0198837287.USD","AMDY","LU0823434740.USD","BK4554","LU0889565833.HKD","BK4614","AMUU","BK4529","BK4534","LU1852331112.SGD","LU1242518931.SGD","CNO","IE0009356076.USD","SLON","LU1880398471.USD","LU2458330169.SGD","LU1989764664.SGD","BK4566","SSK","AMDG","AMDL","LU1880398554.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624531224","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Ocular Therapeutix (OCUL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624531224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624531224?lang=en_us&edition=fundamental","pubTime":"2026-04-01 02:00","pubTimestamp":1774980033,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV), Molina Healthcare (MOH) and Ocular ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbvie-abbv-molina-healthcare-moh-and-ocular-therapeutix-ocul-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbvie-abbv-molina-healthcare-moh-and-ocular-therapeutix-ocul-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1732800096.USD","LU0128525929.USD","XLV","LU1989772840.SGD","SG9999001440.SGD","BK4154","LU0203345920.USD","LABU","LU2237443622.USD","IE00BGHQF631.EUR","SG9999014039.USD","XBI","MOH","LU1003077747.HKD","LU1074936037.SGD","LU0289739699.SGD","LU0795875169.SGD","LU2237443978.SGD","ABBV","LU1989771016.USD","IE00BVYPNW00.USD","LU0738911758.USD","LU0432979614.USD","LU0057025933.USD","LU2237443549.SGD","LU0310799852.SGD","IE00B42XCP33.USD","LU2237443465.HKD","LU0912757837.SGD","IE00BLSP4239.USD","LU0949170772.SGD","LU1244550577.SGD","SG9999014013.SGD","BK4559","LU1929549753.HKD","BK4585","LU2129689431.USD","OCUL","IE0002141913.USD","LU1267930573.SGD","LU0823416689.USD","LU1551013342.USD","LU2133065610.SGD","SG9999011175.SGD","SG9999015945.SGD","LU1023059063.AUD","LU1093756325.SGD","LU0256863902.USD","LU1291159041.SGD","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623364003","title":"Why Ocular Therapeutix (OCUL) Is Down 7.7% After Single‑Trial FDA Plan For AXPAXLI Superiority Claim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364003","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364003?lang=en_us&edition=fundamental","pubTime":"2026-03-29 07:06","pubTimestamp":1774739166,"startTime":"0","endTime":"0","summary":"Earlier this year, Ocular Therapeutix reported that its Phase 3 SOL-1 trial for AXPAXLI in retinal disease met its primary endpoint, showing superiority to EYLEA and prompting plans to seek FDA approval based on this single study while its second Phase 3 trial, SOLAR, continues.\nManagement also addressed reported “floaters,” attributing them to harmless drug particles without vision impact, and argued that the highly treatment‑dependent, high‑vision SOL-1 population may understate how well...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/why-ocular-therapeutix-ocul-is-down-77-after-singletrial-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/why-ocular-therapeutix-ocul-is-down-77-after-singletrial-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BSOL","SOLZ","BK4007","AIYY","BK4588","BK4543","AI","AGIX","BK4585","SLON","BK4551","BK4528","OCUL","AIPO","CHAT","BK4023","LABU","BK4587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828595","title":"Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL) and Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828595?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:40","pubTimestamp":1774608005,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocular Therapeutix (OCUL) and Rhythm Pharmaceuticals...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ocular-therapeutix-ocul-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ocular-therapeutix-ocul-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","HCSG","RYTM","LU0029874061.USD","LABU","BK4581","BK4137","BK4007","OCUL","XLV","XBI","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":124,"code":"91000000","status":"200"}]}}